Clínica Baviera, S.A. (BME:CBAV) said that Corporación Financiera Alba, S.A. (BME:ALB) and other shareholders have obtained a mandate from Rothschild & Co SCA (ENXTPA:ROTH) to evaluate strategic possibilities, including restructuring of shareholding structure of Clinica Baviera. In response to media reports, says that the process is ongoing and Clínica Baviera will inform on any significant developments.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.5 EUR | +0.71% | +0.35% | +23.91% |
Feb. 29 | Clínica Baviera, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Clínica Baviera, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.91% | 500M | |
-18.90% | 16.51B | |
+4.50% | 12.53B | |
+4.81% | 11.74B | |
+2.43% | 10.06B | |
-4.75% | 7.57B | |
+21.11% | 7.22B | |
+5.46% | 6.68B | |
+45.72% | 4.54B | |
-3.49% | 4.32B |
- Stock Market
- Equities
- CBAV Stock
- News Clínica Baviera, S.A.
- Alba Is Evaluating Strategic Options For Clinica Baviera